- Home
- IPHA vs EDF Comparison
IPHA vs EDF Comparison
Compare IPHA & EDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- EDF
- Stock Information
- Founded
- IPHA 1999
- EDF 2010
- Country
- IPHA France
- EDF United States
- Employees
- IPHA N/A
- EDF N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- EDF Investment Managers
- Sector
- IPHA Health Care
- EDF Finance
- Exchange
- IPHA Nasdaq
- EDF Nasdaq
- Market Cap
- IPHA 160.1M
- EDF 148.8M
- IPO Year
- IPHA 2019
- EDF N/A
- Fundamental
- Price
- IPHA $2.18
- EDF $4.92
- Analyst Decision
- IPHA Strong Buy
- EDF
- Analyst Count
- IPHA 1
- EDF 0
- Target Price
- IPHA $11.00
- EDF N/A
- AVG Volume (30 Days)
- IPHA 28.8K
- EDF 160.6K
- Earning Date
- IPHA 03-27-2025
- EDF 01-01-0001
- Dividend Yield
- IPHA N/A
- EDF 13.14%
- EPS Growth
- IPHA N/A
- EDF N/A
- EPS
- IPHA N/A
- EDF N/A
- Revenue
- IPHA $20,831,349.00
- EDF N/A
- Revenue This Year
- IPHA $209.83
- EDF N/A
- Revenue Next Year
- IPHA $83.15
- EDF N/A
- P/E Ratio
- IPHA N/A
- EDF N/A
- Revenue Growth
- IPHA N/A
- EDF N/A
- 52 Week Low
- IPHA $1.29
- EDF $3.51
- 52 Week High
- IPHA $3.51
- EDF $5.50
- Technical
- Relative Strength Index (RSI)
- IPHA 53.46
- EDF 53.61
- Support Level
- IPHA $2.06
- EDF $4.90
- Resistance Level
- IPHA $2.24
- EDF $5.03
- Average True Range (ATR)
- IPHA 0.09
- EDF 0.07
- MACD
- IPHA -0.01
- EDF 0.00
- Stochastic Oscillator
- IPHA 53.33
- EDF 47.22
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About EDF Virtus Stone Harbor Emerging Markets Income Fund of Beneficial Interest
Virtus Stone Harbor Emerging Markets Income Fund is a closed-end management investment company. Its investment objective is to maximize total return, which consists of income from its investments and capital appreciation. The Fund normally will invest at least 80% of its net assets (plus any borrowings for investment purposes) in emerging markets securities.